Table 2. The BH4% in the blood, liver and kidney after 6RBH4 administration.
Time | Rat group | Blood | Liver 1) | Kidney 1), 2) | ||
---|---|---|---|---|---|---|
% | % | % | ||||
30 min | BH4 alone | 93.9 ±0.6 | 98.7 ±0.1 | ** | 98.0 ±0.2 | **, n.s. |
BH4 + Pbc | 89.2 ±0.7 | 98.7±0.1 | ** | 97.7 ±0.3 | **, n.s. | |
BH4 + CsA | 94.4 ±0.1 | 98.6 ±0.1 | ** | 98.1 ±0.4 | **, n.s. | |
120 min | BH4 alone | 96.2 ±0.1 | 98.8 ±0.1 | ** | 98.6 ±0.3 | **, n.s. |
BH4 + Pbc | 87.6 ±3.7 | 98.1 ±0.1 | n.s. | 89.2 ±5.5 | n.s., n.s. | |
BH4 + CsA | 95.3 ±0.1 | 98.5 ±0.1 | ** | 98.4 ±0.1 | **, n.s. |
The BH4% in organs 30 min and 120 min after administration of 6RBH4 with or without prior treatment with Pbc or CsA. For each rat group, differences in the organ BH4% between blood, liver and kidney were analyzed by Tukey’s multiple testing method. BH4% values are means ±S.E. and apply to Fig 5.
1) Difference between the BH4% of time-matched blood vs. liver or kidney. **P<0.01 significance, suggesting the BH4% is higher than that of blood; “n.s.”, not significant.
2) Difference between the BH4% of time-matched liver vs. kidney.